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Immunology SelectInflammation is the body’s defense against infection by pathogens, tissue injury, or cancer. The inflammatory response
requires the eloquent orchestration of multiple networks of cells from both the innate and adaptive immune systems and
their production of and response to a multitude of molecular mediators. This Immunology Select highlights a cluster of
new studies that shed fresh light on the biology of some of the lymphoid and myeloid cell types involved in inflammation.New Cells Hang Out In A Greasy Neighborhood
Cells of the innate immune system such as neutrophils and macrophages are the ‘‘first responders’’ during the initial steps of
inflammation, rushing to the scene of pathogen invasion. All white blood cells of the myeloid lineage, including neutrophils and
macrophages, are ‘‘innate-type’’ immune cells, but the only lymphoid cells that are also considered innate immune cells are natural
killer (NK) cells. Moro et al. (2010) now identify a new comrade-in-arms for NK cells, a second ‘‘innate-type’’ lymphoid cell with a
surprising location and with functional properties complementary to those of NK cells. The new kid on the innate immune system
block is found in previously unrecognized cell clusters named ‘‘fat associated lymphoid clusters’’ (FALCs), present in adipose tissue
located along the blood vessels of the mouse and human peritoneal cavity. Although this cell subpopulation has the morphological
characteristics of lymphoid cells, they could not be persuaded to differentiate into T, B, or NK lymphoid lineages. They have been
christened ‘‘natural helper (NH) cells.’’ Unlike NK cells, which are innate lymphoid cells capable of secreting the cytokine IFN-g,
NH cells secrete IL-4, IL-5, and IL-13. Moro and colleagues identified three key functions for this new cell population. NH cells
produce IL-5, which drives self-renewal of a subset of B lymphocytes in the peritoneal cavity. Secondly, they boost the secretion
of IgA antibody by B cells in the spleen. Finally, by secreting IL-13, NH cells induce excess mucin secretion by goblet cells in the
gut and, in so doing, facilitate the expulsion of a parasitic worm called Nippostrongylus brasiliensis in a mouse model of parasitic
infection. Therefore, this new innate immune lymphocyte is able to join forces with its more celebrated NK cousin to fight invasion
by pathogens. Yet why do these cells reside in fat tissue, a rather unusual neighborhood? Might fat tissue be the equivalent of potato
chips for NH cells?
K. Moro et al. (2010). Nature 463, 540–544.Another Mercenary Molecule in the Innate Immune System
Natural killer (NK) cells may have acquired a new cousin, but they seem to have lost a sentinel inhibitory receptor, Ly49Q. In their new
study, Sasawatari et al. (2010) identify Ly49Q, a member of the Ly49 family of inhibitory receptors expressed by NK cells, as a rene-
gade. It turns out that Ly49Q is not expressed by NK cells at all but is expressed by neutrophils as well as other myeloid lineage cells
expressing the marker Gr-1. The authors show that Ly49Q inhibits neutrophil pseudopod formation and hence migration under
certain conditions while promoting it under others. More specifically, they demonstrate that when neutrophils are exposed to the
chemotactic peptide fMLP, Ly49Q along with its MHC class I ligand (H-2 Kb) is internalized into endosomal compartments within
the same neutrophil. Interestingly, upon stimulation of neutrophils, the phosphatase SHP-2 associates with H-2 Kb, and this
association is dependent on Ly49Q. Ly49Q localizes to lipid rafts and is responsible for recruitment of Src and SHP-2 to the rafts.
Subcellular redistribution of lipid raft components, which form platforms for chemokine signaling via Src-family kinases, is important
for pseudopod formation and migration of neutrophils, and SHP-2 positively regulates Src kinase activity. When the investigators
treated neutrophils with fMLP, those neutrophils expressing (but not those lacking) Ly49Q exhibited a time-dependent increase in
Src activation and were found to adhere firmly to fibronectin substrates. Meanwhile, neutrophils cultured in the absence of fMLP
were easily detached from their substrate. These results paint a picture whereby Ly49Q inhibits neutrophil adhesion and spreading
in the absence of chemoattractant but promotes adhesion and pseudopod formation when the neutrophils are exposed to appro-
priate stimuli. It will be interesting to address the biological significance of the association of Ly49Q with H-2 Kb on the same neutro-
phil as well as the mode of transfer of signaling information from the fMLP receptor to Ly49Q. Nonetheless, Sasawatari and
colleagues offer an interesting biological story of a renegade signaling molecule that can be persuaded to work either in favor of
immune homeostasis (by blocking neutrophil migration) or in favor of inflammation (by promoting neutrophil migration) depending
on the highest bidder.
S. Sasawatari et al. (2010). Immunity 32, 200–213.T Cell Receptors Send Their Flock For Indoctrination
T lymphocytes are critical elements of the cell-mediated immune response. Expression of the coreceptors CD4+ and CD8+ function-
ally distinguishes the two subpopulations of T lymphocytes responsible for supporting antibody-based and cell-mediated immunity,
respectively. The bifurcation of these lineages in the thymus is thought to occur through differences in T cell receptor (TCR) signaling
in thymocyte progenitor cells. The kinetic signaling model proposes that persistent signaling through the TCR in the thymus drives
thymocytes to express the transcription factor ThPOK and to differentiate into CD4+ helper T cells. In contrast, interruption of TCR
signaling permits cytokine signals to drive differentiation of thymocytes into CD8+ cytotoxic T cells, which in turn depends on
induction of the transcription factor Runx3. In new work, Park et al. (2010) report that differentiation of thymocytes into CD8+
T cells can occur in the absence of signaling through the TCR provided that immature thymocytes are rendered responsive to the
cytokine IL-7 and that the local environment is enriched for IL-7. The authors tested the link between cytokine signaling and
Runx3 expression by treating thymocytes with IL-7 at a critical stage of development in vitro. Most interestingly, mice genetically
engineered to contain IL-7-responsive thymocytes that could not signal through their TCR had no CD8+ T cells. However, these
thymocytes could generate huge numbers of CD8+ T cells in the thymus if the mouse expressed a transgene for IL-7 and startedCell 140, March 19, 2010 ª2010 Elsevier Inc. 759
to produce this cytokine. These observations suggest that it is IL-7 signaling, not TCR signaling, that is the actual driver of CD8+ T cell
differentiation. Finally, the authors note that wild-type thymocytes with intact TCR signaling upregulate a chemokine receptor called
CCR7, which induces their migration from the thymic cortex to the cytokine-rich thymic medulla where there are likely to be ample
amounts of IL-7. Therefore, like a proud parent, the TCR may take credit for raising its thymocytes to become mature CD8+ T lympho-
cytes, when in fact the TCR is simply putting the children on the school bus. Indeed, it is instructions from the IL-7 teacher that actually
inculcate thymocytes with the knowledge to become mature members of the lymphocyte community.
J.H. Park et al. (2010). Nat. Immunol. 11, 257–264.Compared to untreated dendritic cells (red; left), those
treated with ovalbumin are lysed by Treg cells in the lymph
node (arrow; right). Photo courtesy of S. Amigorena.Terminate with Extreme Prejudice
Regulatory T (Treg) cells are a sublineage of CD4+ helper T cells that
can downmodulate the immune response. Tumor cells have generated
clever ways to escape immune detection including the ability to
generate and recruit Treg cells to aid in this process. Ex vivo studies
suggest that Treg cells are able to limit antitumor immunity through
a variety of mechanisms including the killing of CD8+ T cells, B cells,
and NK cells. Boissonnas et al. (2010) set out to discover if this killer
activity of Treg cells could be replicated in vivo. The authors used
dynamic intravital imaging in mice with mammary tumors to demon-
strate in vivo that Treg cells can directly kill dendritic cells presenting
a model tumor antigen (ovalbumin). The killing event was dependent
on the dendritic cells expressing both ovalbumin and MHC class II
and required physical contact with the Treg cells. Moreover, the Treg
cell’s killing ability depended on the expression of the pore-forming
protein perforin by these cells. Notably, decreasing the accumulation
of Treg cells in the tumor-draining lymph node through inactivation resulted in a decrease in the motility of ovalbumin-specific
CD8+ T cells. This boosted the interaction between the antigen-presenting dendritic cells and the CD8+ T cells, resulting in improved
T cell activation and hence antitumor immunity. The amount of the proinflammatory cytokine IFN-g (a measure of T cell activation) was
higher in the tumor-draining lymph node in mice with inactivated Treg cells than in wild-type mice, thus correlating enhanced CD8+
T cell activation with a decrease in the motility of these cells. It will be interesting to determine whether the mechanism by which
Treg cells influence the motility of CD8+ T cells can be attributed to an effect on actin polymerization and whether other leukocytes
in the draining lymph node are similarly affected. Thus the ability of Treg cells to terminate dendritic antigen-presenting cells with
extreme prejudice can now be added to the armamentarium of strategies available to Treg cells in their quest to dampen antitumor
immunity.
A. Boissonnas et al. (2010). Immunity 32, 266–278.GABAergic agents reduce neuroinflammation.
Image provided by R. Bhat.Tranquilizers for the Immune System
g-Aminobutyric acid (GABA) is a critical negative regulator of neurotransmission in
the central nervous system (CNS). Like many biological mediators, this neuro-
transmitter is promiscuous, also exerting effects on immune cells. Bhat et al.
(2010) now characterize the effects of GABA on antigen-presenting cells such
as macrophages and reveal its potential to regulate autoimmune inflammation
in the CNS. They show that all of the biochemical components needed to synthe-
size and metabolize GABA are present in macrophages. Electrical responses are
seen in the membranes of macrophages after application of GABA. Macrophages
purified from a mouse treated with GABA and then exposed in vitro to the MOG
(myelin oligodendrocyte glycoprotein) peptide were less effective at driving IFN-
g secretion by MOG-specific T cells. The diminished potency of GABA-exposed
macrophages correlated with a decrease in phosphorylation of the signalingkinases p38 MAPK and p42/44 ERK. The authors next tested the role of GABA in mice with an inflammatory disease, in this case
experimental autoimmune encephalitis (a model of multiple sclerosis) induced by injection of MOG. GABAergic treatment delayed
onset and decreased the severity of disease symptoms. GABA could also partly reverse paralysis when treatment was administered
after disease onset. The relevant target of GABAergic treatment in this physiological model was immune cells rather than neuronal
cells as adoptive transfer of GABAergic-treated spleen cells into a naive mouse delayed disease onset. This study continues the
process of unraveling the molecular role of GABA in the function of antigen-presenting cells and other immune cells. Could GABA
provide a functional bridge between the brain and the immune system? When GABA levels are elevated, for example in certain neuro-
logical diseases, are there consequences for immune function? This contribution by Bhat and colleagues advances our under-
standing of crosstalk between the CNS and the immune system and reminds us that tranquilizers may not only be effective for
your nerves.
R. Bhat et al. (2010). Proc. Natl. Acad. Sci. USA 107, 2580–2585.
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